Catheter Ablation for Common Cardiac Arrhythmias: Where We Are and Where Do We Go from Here

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Sunday, April 3, 2:00-3:30 PM

The use of catheter ablation for rhythm abnormalities is on the rise. Newer technology and techniques, as well as a better understanding of underlying disease mechanisms, have propelled the case for ablation for many physicians and patients alike.

With atrial fibrillation, the decision to ablate might seem routine: if antiarrhythmic drugs don't work, then ablate. By no means is the book on AF ablation closed, but neither is one regarding ablation of less complex arrhythmias.

This session is for cardiologists and EPs who want to better understand the nuances involved with supraventricular tachycardia (SVT). Should you ablate? If so, when? Should you not ablate? If not, will there be a time in the future to reconsider?

These lectures promise to bring all of those questions and more to the forefront in a lively debate format, preceded by in-depth overviews of the indications, approaches and outcomes.

They may be called less complex arrhythmias, but that doesn't mean they are any less challenging to the practitioner who wants to personalize his or her approach.

Speaker Information

  • Aman Chugh, MD, University of Michigan Health System, Ann Arbor, Mich. -- Overview: Indications, Approaches and Outcomes
  • A. John Camm, MD, St. George's University, London -- Fallacies of Ablation Therapy and Reasons to Delay and/or Withhold It
  • Karl-Heinz Kuck, MD, Allegemienes Krankenhaus St. Georg, Hamburg, Germany -- Benefits and Reasons to Pursue This Strategy and Intervene Early
  • Henry H. Hsia, MD, Stanford School of Medicine, Palo Alto, Calif. -- Overview: Indications, Approaches and Outcomes
  • Martin Borggrefe, MD, Cardiology University Hospital of Mannheim, Germany -- Fallacies of Ablation Therapy and Reasons to Withhold
  • William G. Stevenson, MD, Brigham and Women's Hospital, Boston -- Benefits and Reasons to Pursue This Strategy Aggressively and Intervene Early
  • Melvin M. Scheinman, MD, University of California, San Francisco -- Overview: SVT Mechanisms, Ablation Approaches and Outcomes
  • Eric N. Prystowsky, MD, St. Vincent Hospital, Indianapolis -- Are There Reasons Why Ablation Therapy Should Not Be the First Option in the Management of SVT?